Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Global Market Value Of The Sexually Transmitted Disease (STD) Self-Testing Industry In 2025?
The market size for sexually transmitted disease (STD) self-testing has experienced rapid growth over the past few years. This market is projected to expand from $1.38 billion in 2024 to reach $1.52 billion by 2025, achieving a compound annual growth rate (CAGR) of 10.1%. Historically, this expansion has been driven by factors such as heightened awareness of sexual health, greater uptake of at-home healthcare options, an increase in government-sponsored STD screening programs, the growing availability of over-the-counter self-test kits, and heightened apprehension regarding privacy during clinic-based testing.
The sexually transmitted disease (STD) self-testing market is projected to experience substantial expansion in the coming years, with its size anticipated to reach $2.21 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.8%. This expansion throughout the forecast period is primarily driven by the increasing occurrence of sexually transmitted infections, a rising need for easy-to-use and confidential testing options, greater incorporation of digital health into self-test kits, wider availability of at-home diagnostics in developing regions, and the increasing authorization of sophisticated self-testing innovations by regulatory bodies. Key trends anticipated during this period encompass progress in rapid molecular diagnostic technologies, enhanced mobile application integration for tracking results, the creation of self-test kits capable of detecting multiple infections, novel approaches to discreet packaging and delivery, and improvements in AI-driven interpretation of test outcomes.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp
What Are The Top Growth Drivers Impacting The Sexually Transmitted Disease (STD) Self-Testing Market Outlook?
The increasing occurrence of syphilis is projected to stimulate the expansion of the sexually transmitted disease (STD) self-testing market moving forward. Syphilis is a sexually transmitted infection that causes lesions on the body and can lead to severe health issues if left untreated. The rise in syphilis cases is linked to a decrease in consistent condom usage, particularly among groups engaging in high-risk sexual activities. STD self-testing provides a discreet and convenient option for at-home screening for syphilis, encouraging prompt diagnosis. This early identification ensures timely intervention, reducing complications and preventing further spread. For example, according to the Centers for Disease Control and Prevention, a US-based government agency, approximately 209,253 syphilis cases were reported in 2023, marking a 1% increase from 207,269 cases in 2022. Thus, the escalating incidence of syphilis is a primary factor driving the growth of the sexually transmitted disease (STD) self-testing market.
What Are The Different Segment Classifications Within The Sexually Transmitted Disease (STD) Self-Testing Market?
The sexually transmitted disease (std) self-testing market covered in this report is segmented –
1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test
2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications
Subsegments:
1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device
2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection
3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection
Which Competitive Trends Are Defining The Sexually Transmitted Disease (STD) Self-Testing Market Structure?
Leading companies in the STD self-testing market are concentrating on developing advanced products, such as over-the-counter (OTC) sample collection kits, to encourage early detection and timely treatment of infections. These OTC sample collection kits serve as at-home diagnostic tools, enabling individuals to gather samples like urine or swabs without needing a prescription. They provide a convenient and confidential method for early infection detection, thereby facilitating prompt treatment. For instance, in August 2023, iHealth Labs Inc., a US-based digital health company, introduced the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved kit allows individuals aged 18 and older to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the comfort and privacy of their own homes. Users can mail their samples to the lab using a prepaid overnight label and receive confidential, reliable results in as little as two days. The kit offers highly accurate results, with sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples undergo analysis in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with strict federal and state quality standards through regular inspections.
Which Key Players Are Driving Competition In The Sexually Transmitted Disease (STD) Self-Testing Market?
Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.
Download The Full Report For Exclusive Market Findings:
How Do Regional Market Performances Compare Within The Sexually Transmitted Disease (STD) Self-Testing Industry?
North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Sexually Transmitted Disease (STD) Self-Testing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25901&type=smp
Browse Through More Reports Similar to the Global Sexually Transmitted Disease (STD) Self-Testing Market 2025, By The Business Research Company
Std Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report
Sexually Transmitted Infections Stis Global Market Report 2025
Chlamydia Trachomatis Ct And Neisseria Gonorrhoeae Ng Testing Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model